Lab Overview We seek to leverage modern genomic and genome-scale functional genetic technologies to dissect the molecular underpinnings and vulnerabilities of cancer. We have a focus on understanding genitourinary cancers (especially cancers of the prostate and kidney), with a particular interest in elucidating how alterations in the noncoding genome or in RNA processing pathways may drive these diseases.
Mission Our overarching mission is to make scientific discoveries that accelerate the development of life-extending treatments for patients with cancer, with a focus on those with genitourinary cancers. We aim to elucidate the drivers and vulnerabilities of genitourinary cancers by integrating genomic profiling of primary tissue specimens with functional approaches in in vitro and in vivo systems. We are a highly collaborative research group engaged in joint projects with scientists and clinicians of diverse expertise. In addition to basic and translational research output, we are also deeply committed to mentoring the next generation of physicians and scientists.
Positions Available! Please click here if you are interested in joining the team!
2021-04-15: New preprint on the genomic landscape translocation renal cell carcinoma now on bioRxiv
Link here. 2020-07-20: Welcome Vidya; goodbye and good luck to Stephen! 2020-06-18: First preprint from the lab is up on BioRxiv. Link here. 2020-05-28: We're back! Excited to reopen the lab and welcome to Shatha, who officially joined the lab during the research shutdown! 2020-03-20: Shutting down the lab for the COVID pandemic...stay safe everyone! 2020-02-18: Welcome Jiao! 2019-09-23: Welcome Nebiyou! 2019-09-04: Welcome Emma! 2019-08-01: Welcome Stephen! 2019-08-01: Hello World! The Viswanathan Lab is